Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Guanggu Humanwell Biomedical is a specialized subsidiary of Humanwell Healthcare Group, located in the Optics Valley (Guanggu) region of Wuhan, China. The company serves as a major R&D and manufacturing hub, focusing on the development of innovative biological drugs, recombinant proteins, and high-end pharmaceutical preparations. It plays a critical role in supporting Humanwell's market-leading position in the anesthesiology and analgesia sectors while expanding the group's capabilities into advanced biotechnologies. The company operates large-scale, GMP-compliant facilities designed to meet both domestic and international regulatory standards for drug production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Guanggu Humanwell Biomedical.